Clinical Trials Logo
  1. Home
  2. Restless Leg Syndrome
  3. NCT01538147
  4. Details
NCT01538147 Clinical Trial

Restless Leg Syndrome and Severe Preeclampsia

Restless Leg Syndrome Clinical Trial

Official title:
Association Between Restless Leg Syndrome and Severe Preeclampsia. A Case Control Study.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01538147
Other study ID # MHST2012-02
Secondary ID
Status Completed
Phase N/A
First received February 19, 2012
Last updated January 2, 2018
Start date August 1, 2017
Est. completion date December 15, 2017

Study information
Verified date January 2018
Source Saint Thomas Hospital, Panama
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Restless Leg Syndrome is a common but not well recognized central nervous system disorder. It is more prevalent during pregnancy and, if present before pregnancy, can develop an exacerbation of symptoms. In some of the hypothesis trying to explain this syndrome, the physiopathology can also explain hypertensive disorders of pregnancy. So far, no study has been done trying to link both disorders.

Recruitment information / eligibility
Status Completed
Enrollment 310
Est. completion date December 15, 2017
Est. primary completion date November 30, 2017
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Gestational age between 24-34 weeks

- Severe preeclampsia

Exclusion Criteria:

- Neurological disorders (central nervous system)

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Panama Saint Thomas Maternity Hospital Panama

Sponsors (1)
Lead Sponsor Collaborator
Saint Thomas Hospital, Panama

Country where clinical trial is conducted

Panama, 

Outcome
Type Measure Description Time frame Safety issue
Primary Restless Leg Syndrome Number of patients with criteris for the diagnosis of Restless Leg Syndrome 10 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01931878 - Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. Phase 2
Completed NCT01672502 - Fire Fighter Fatigue Management Program: Operation Fight Fatigue N/A
Completed NCT02085720 - Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance N/A
Completed NCT03337529 - Restless Legs Syndrome in Hemodialysis Patients N/A
Completed NCT01245777 - Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy Phase 4
Completed NCT01617044 - Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome Phase 2
Not yet recruiting NCT06233773 - The Effect of Kinesio Taping and Manual Lymph Drainage on Pregnant Women With Restless Legs Syndrome N/A
Recruiting NCT02016638 - Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes N/A
Completed NCT01988129 - Fire Fighter Fatigue Management Program: Operation Healthy Sleep N/A
Completed NCT00949858 - New Data Analysis Methods for Actigraphy in Sleep Medicine N/A
Completed NCT03818243 - Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome N/A
Completed NCT00872248 - Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean N/A
Completed NCT00674310 - A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions N/A
Completed NCT00673088 - A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions N/A
Terminated NCT02117076 - Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome Phase 4
Completed NCT02386423 - RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome N/A